252 related articles for article (PubMed ID: 27735156)
1. Primary Maxillary Sinus Plasmablastic Lymphoma in HIV/AIDS.
Basavaraj A; Kadam M; Kadam DB
J Assoc Physicians India; 2016 May; 64(5):71-72. PubMed ID: 27735156
[TBL] [Abstract][Full Text] [Related]
2. Plasmablastic lymphoma: an atypical cutaneous presentation of a rare entity.
Mota F; Mesquita B; Carvalho S; Coelho A; Velho G; Lima M; Selores M
Dermatol Online J; 2016 May; 22(5):. PubMed ID: 27617520
[TBL] [Abstract][Full Text] [Related]
3. Plasmablastic lymphoma: successful management with CHOP and lenalidomide in resource constraint settings.
Yanamandra U; Sahu KK; Jain N; Prakash G; Saikia U; Malhotra P
Ann Hematol; 2016 Oct; 95(10):1715-7. PubMed ID: 27324386
[No Abstract] [Full Text] [Related]
4. Paying more than lip service to an oral lesion: a case of plasmablastic lymphoma.
Moayedi Y; Venos ES; Ghaffar H; Gough KA; Hicks LK
BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22802569
[TBL] [Abstract][Full Text] [Related]
5. Unilateral Maxillary Sinus Plasmablastic Lymphoma in an Immunocompetent Patient. An Unusual Occurrence Report and Literature Review.
Chicuellar NR; Sufyan W; Mahendran S
Ear Nose Throat J; 2022 Jul; 101(6):NP251-NP255. PubMed ID: 33044847
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous plasmablastic lymphoma revealing clinically unsuspected HIV infection.
Marques SA; Abbade LP; Guiotoku MM; Marques ME
An Bras Dermatol; 2016; 91(4):507-9. PubMed ID: 27579749
[TBL] [Abstract][Full Text] [Related]
7. A tip of the iceberg: Disseminated plasmablastic lymphoma, diagnosed from a local oral lesion.
Ke YL; Hsiao HH; Cho SF; Wu CC
Kaohsiung J Med Sci; 2021 Apr; 37(4):346-347. PubMed ID: 33340392
[No Abstract] [Full Text] [Related]
8. HIV-associated plasmablastic lymphoma: A single-centre 12-year experience in Kwa-Zulu Natal, South Africa.
Rapiti N; Peer N; Abdelatif N; Rapiti P; Moosa Y
HIV Med; 2022 Sep; 23(8):837-848. PubMed ID: 35229978
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
[TBL] [Abstract][Full Text] [Related]
10. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.
Noy A; Lensing SY; Moore PC; Gupta N; Aboulafia D; Ambinder R; Baiocchi R; Dezube BJ; Henry D; Kaplan L; Levine AM; Mitsuyasu R; Ratner L; Reid E; Remick S; Sparano J; Tzachanis D; Wachsman W; Chadburn A
Leuk Lymphoma; 2016 Jul; 57(7):1731-4. PubMed ID: 26674561
[No Abstract] [Full Text] [Related]
11. Disseminated plasmablastic lymphoma.
Sharma R; Abdou S; Plymyer MR; Rohatgi C
J Am Coll Surg; 2004 Oct; 199(4):654-5. PubMed ID: 15454154
[No Abstract] [Full Text] [Related]
12. [A Case of Malignancy-induced Lactic Acidosis Having Difficulty with Diagnosis].
Tamura E; Taniguchi Y; Nishiyama M; Yatabe T; Inoue K; Arakawa Y; Mori M; Ikezoe T; Terada Y; Fujimoto S
Nihon Naika Gakkai Zasshi; 2016 Jun; 105(6):1041-50. PubMed ID: 30168696
[No Abstract] [Full Text] [Related]
13. Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.
Castillo JJ; Winer ES; Stachurski D; Perez K; Jabbour M; Milani C; Colvin G; Butera JN
Oncologist; 2010; 15(3):293-9. PubMed ID: 20167839
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.
Wang D; Zheng Y; Zeng D; Yang Y; Zhang X; Feng Y; Lu H
Int J STD AIDS; 2017 Mar; 28(4):380-388. PubMed ID: 27164966
[TBL] [Abstract][Full Text] [Related]
15. Dramatic treatment response of cutaneous plasmablastic lymphoma in an HIV patient: a case report.
Sakib SM; Sadler M
Clin Imaging; 2016; 40(6):1067-1069. PubMed ID: 27408991
[TBL] [Abstract][Full Text] [Related]
16. Solitary plasmablastic lymphoma in the esophagus.
Mihara K; Sasaki N; Mamoru O; Kanbe M; Ichinohe T; Suehiro S
Ann Hematol; 2016 Apr; 95(5):845-6. PubMed ID: 26925582
[No Abstract] [Full Text] [Related]
17. Plasmablastic lymphoma: a case report.
Toure G; Roucayrol AM; Meningaud JP; Bertrand JC
Quintessence Int; 2007 Feb; 38(2):161-3. PubMed ID: 17263156
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients with plasmablastic lymphoma: a retrospective analysis.
Dittus C; Grover N; Ellsworth S; Tan X; Park SI
Leuk Lymphoma; 2018 Sep; 59(9):2121-2127. PubMed ID: 29303024
[TBL] [Abstract][Full Text] [Related]
19. Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing Outcomes.
Hunter NB; Vogt S; Ambinder RF
Oncology (Williston Park); 2017 Dec; 31(12):872-7, 884. PubMed ID: 29297171
[TBL] [Abstract][Full Text] [Related]
20. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients.
Mai B; Wang W; Lin M; Hu S; Wang XI; Chen L; Wahed A; Nguyen A; Ma HY; Medeiros LJ; Hu Z
AIDS; 2020 Oct; 34(12):1735-1743. PubMed ID: 32889849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
